Bank of America Securities Sticks to Their Sell Rating for Align Tech (ALGN)
In a report released yesterday, Michael Ryskin from Bank of America Securities maintained a Sell rating on Align Tech, with a price target of $175.00.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Ryskin is a 3-star analyst with an average return of 1.1% and a 47.33% success rate. Ryskin covers the Healthcare sector, focusing on stocks such as Zoetis, Bruker, and Idexx Laboratories.
Align Tech has an analyst consensus of Moderate Buy, with a price target consensus of $199.27.
Based on Align Tech’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.05 billion and a net profit of $135.76 million. In comparison, last year the company earned a revenue of $995.22 million and had a net profit of $103.81 million
Read More on ALGN:
Disclaimer & DisclosureReport an Issue
- Early notable gainers among liquid option names on March 19th
- Morning Movers: Canadian Solar sinks following fourth quarter results
- Elliott builds stake in Align, to seek ways to lift stock price, Bloomberg says
- Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK
- DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
